Skip to main content

The Globe and Mail

CanniMed announces agreement to supply medical cannabis to PharmaChoice

A cannabis plant is shown in southwest Quebec on Oct. 8, 2013.

Justin Tang/THE CANADIAN PRESS

CanniMed Therapeutics Inc. says it has entered into a definitive agreement with PharmaChoice to supply herbal, oils and oil-derivative cannabis products to its more than 750 pharmacy locations across Canada.

The Saskatoon-based company says PharmaChoice has committed exclusively to CanniMed as its sole supplier of cannabis products, subject to CanniMed meeting certain product and volume requirements.

Earlier this year, CanniMed signed a letter of intent with member-owned co-operative PharmaChoice to be its exclusive medical cannabis distributor and to train its pharmacists and pharmacy technicians.

Story continues below advertisement

The company says its deal with PharmaChoice is still conditional on Health Canada's approval of medical cannabis product distribution through pharmacies.

CanniMed's supply agreement comes a day after it was notified that the Toronto Stock Exchange will defer consideration of a shareholder rights plan adopted by the company in a bid to defend itself against a hostile takeover offer by Aurora Cannabis Inc.

The rights plan prevents Vancouver-headquartered Aurora from acquiring any CanniMed shares other than those tendered to its hostile bid or from entering into any lock-up agreements other than those it has already signed and filed, CanniMed has said.

Packaging that won’t ‘entice’ youth among cannabis proposals (The Canadian Press)
Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

Please note that our commenting partner Civil Comments is closing down. As such we will be implementing a new commenting partner in the coming weeks. As of December 20th, 2017 we will be shutting down commenting on all article pages across our site while we do the maintenance and updates. We understand that commenting is important to our audience and hope to have a technical solution in place January 2018.

Discussion loading… ✨